Stratos Wealth Partners LTD. purchased a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 2,583 shares of the medical device ...
JAMA today published outcomes from a study evaluating the safety and efficacy of the Insulet Omnipod 5 in adults with type 2 ...
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an ...
Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...
Barchart on MSN23h
DexCom Stock Outlook: Is Wall Street Bullish or Bearish?San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that focuses on the design, development, and ...
In a report released today, Patrick Wood from Morgan Stanley maintained a Hold rating on Dexcom (DXCM – Research Report), with a price target ...
Hosted on MSN23h
DexCom Stock Rises Despite Q4 Earnings Miss & Lower MarginsDexCom, Inc. DXCM reported fourth-quarter 2024 adjusted earnings per share (EPS) of 45 cents, which missed the Zacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback